Mots-clés
Documents disponibles dans cette catégorie (411)
Article : Périodique
H. A. WHITEFORD ; L. DEGENHARDT ; J. REHM ; A. J. BAXTER ; A. J. FERRARI ; H. E. ERSKINE ; F. J. CHARLSON ; R. E. NORMAN ; A. D. FLAXMAN ; N. JOHNS ; R. BURSTEIN ; C. J. L. MURRAY ; T. VOS |BACKGROUND: We used data from the Global Burden of Diseases, Injuries, and Risk Factors Study 2010 (GBD 2010) to estimate the burden of disease attributable to mental and substance use disorders in terms of disability-adjusted life years (DALYs)[...]Article : Périodique
K. DOLAN ; A. L. WIRTZ ; B. MOAZEN ; M. NDEFFO-MBAH ; A. GALVANI ; S. A. KINNER ; R. COURTNEY ; M. McKEE ; J. J. AMON ; L. MAHER ; M. HELLARD ; C. BEYRER ; F. L. ALTICE |The prison setting presents not only challenges, but also opportunities, for the prevention and treatment of HIV, viral hepatitis, and tuberculosis. We did a comprehensive literature search of data published between 2005 and 2015 to understand t[...]Article : Périodique
S. COLLEDGE-FRISBY ; S. OTTAVIANO ; P. WEBB ; J. GREBELY ; A. WHEELER ; E. B. CUNNINGHAM ; B. HAJARIZADEH ; J. LEUNG ; A. PEACOCK ; P. VICKERMAN ; M. FARRELL ; G. J. DORE ; M. HICKMAN ; L. DEGENHARDT |BACKGROUND: Harm reduction and treatment programmes are essential for reducing harms for people who inject drugs (PWID). We aimed to update estimates from a 2017 review of global coverage of needle and syringe exchange programmes (NSPs), opioid [...]Rapport
FRANÇAIS : L'espérance de vie de la population mondiale pourrait être augmentée d'environ cinq ans si l'on s'attaquait à cinq facteurs de risques : l'insuffisance pondérale pendant l'enfance, les rapports sexuels à risque, l'alcoolisme, le man[...]Rapport
In May 2016, the World Health Assembly endorsed the Global Health Sector Strategy (GHSS) on viral hepatitis 2016-2021. The GHSS calls for the elimination of viral hepatitis as a public health threat by 2030 (reducing new infections by 90% and mo[...]Chapitre
FRANÇAIS : L'auto-injection de drogues a des aspects différents d'un pays à l'autre liés aux influences ethniques, économiques, historiques et politiques. Les auteurs passent en revue la situation dans les différentes parties du monde (Amériqu[...]Article : Périodique
L. DEGENHARDT ; A. PEACOCK ; S. COLLEDGE ; J. LEUNG ; J. GREBELY ; P. VICKERMAN ; J. STONE ; E. B. CUNNINGHAM ; A. TRICKEY ; K. DUMCHEV ; M. LYNSKEY ; P. GRIFFITHS ; R. P. MATTICK ; M. HICKMAN ; S. LARNEY |Background: Sharing of equipment used for injecting drug use (IDU) is a substantial cause of disease burden and a contributor to blood-borne virus transmission. We did a global multistage systematic review to identify the prevalence of IDU among[...]Brochure
OMS / WHO | 1993FRANÇAIS : Cette brochure se compose de trois chapitres: une introduction décrivant la pandémie du sida avec tableaux chiffrés, les modes de transmission du VIH, la progression de l'infection vers la maladie et les interactions avec d'autres ma[...]Article : Périodique
S. LARNEY ; A. PEACOCK ; J. LEUNG ; S. COLLEDGE ; M. HICKMAN ; P. VICKERMAN ; J. GREBELY ; K. V. DUMCHEV ; P. GRIFFITHS ; L. HINES ; E. B. CUNNINGHAM ; R. P. MATTICK ; M. LYNSKEY ; J. MARSDEN ; J. STRANG ; L. DEGENHARDT |Background: People who inject drugs (PWID) are a key population affected by the global HIV and hepatitis C virus (HCV) epidemics. HIV and HCV prevention interventions for PWID include needle and syringe programmes (NSP), opioid substitution ther[...]Article : Périodique
J. GREBELY ; S. LARNEY ; A. PEACOCK ; S. COLLEDGE ; J. LEUNG ; M. HICKMAN ; P. VICKERMAN ; S. BLACH ; E. B. CUNNINGHAM ; K. DUMCHEV ; M. LYNSKEY ; J. STONE ; A. TRICKEY ; H. RAZAVI ; R. P. MATTICK ; M. FARRELL ; G. J. DORE ; L. DEGENHARDT |BACKGROUND AND AIMS: People who have recently injected drugs are a priority population in efforts to achieve hepatitis C virus (HCV) elimination. This study estimated the prevalence and number of people with recent injecting drug use living with[...]Article : Périodique
Background: The Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2017 comparative risk assessment (CRA) is a comprehensive approach to risk factor quantification that offers a useful tool for synthesising evidence on risks and r[...]Article : Périodique
Background: The Global Burden of Diseases, Injuries, and Risk Factors Study 2017 (GBD 2017) includes a comprehensive assessment of incidence, prevalence, and years lived with disability (YLDs) for 354 causes in 195 countries and territories from[...]Article : Périodique
Background: Improving survival and extending the longevity of life for all populations requires timely, robust evidence on local mortality levels and trends. The Global Burden of Disease 2015 Study (GBD 2015) provides a comprehensive assessment [...]Article : Périodique
AIMS: Addiction science has made great progress in the past decades. We conducted a scientometric study in order to quantify the number of publications and the growth rate globally, regionally, and at country levels. METHODS: In October 2015, w[...]Rapport
The special segment of the current issue reviews the latest developments on synthetic substances that are not under international control. Over the past months, these substances have become more widespread in established ATS (amphetamine-type st[...]Rapport
The special segment of the current issue reviews the changing approach of illicit ATS (amphetamine-type stimulants) manufacture by drug trafficking organizations. International efforts to control the trade of precursor chemicals have resulted in[...]Rapport
The special segment of the current issue takes a closer look at new psychoactive substances (NPS) - substances which are not controlled under the international drug conventions but which have emerged in all regions of the world and may pose a ri[...]Rapport
The Global SMART Update is designed to provide regular brief reports on emerging patterns and trends of the global synthetic drug situation. The current issue provides an overview of NPS trends, challenges and legal approaches in light of the r[...]Article : Périodique
A. PEACOCK ; J. LEUNG ; S. LARNEY ; S. COLLEDGE ; M. HICKMAN ; J. REHM ; G. A. GIOVINO ; R. WEST ; W. HALL ; P. GRIFFITHS ; R. ALI ; L. GOWING ; J. MARSDEN ; A. J. FERRARI ; J. GREBELY ; M. FARRELL ; L. DEGENHARDT |AIMS: This review provides an up-to-date curated source of information on alcohol, tobacco and illicit drug use and their associated mortality and burden of disease. Limitations in the data are also discussed, including how these can be addresse[...]Rapport
Synthetic drugs are taking an ever-greater share of the illicit drugs market. New psychoactive substances (NPS) are also flooding a market for synthetic drugs long dominated by amphetamine-type stimulants (ATS), such as ecstasy and methamphetami[...]Rapport
The 2017 Global Synthetic Drugs Assessment provides an analysis of the global synthetic drugs market in two parts. The first part consists of regional overviews that highlight context-specific dynamics relating to the demand and supply of Amphet[...]Rapport
The Global Synthetic Drugs Assessment 2020 provides an analysis of the global synthetic drugs market. The first part of this report provides options for responses to counter the synthetic drug problem. The second part presents a global thematic [...]Article : Périodique
Background: Gamma-hydroxybutyrate (GHB) overdose is an important concern in the Netherlands and Flanders, Belgium and accounts for most overdoses reported by emergency services. Few stu dies have focused on GHB overdose. Appropriate public healt[...]Article : Périodique
Un rappel historique des conflits entre l'Angleterre et la Chine concernant l'opium, suggère l'enjeu économique prévalent dans l'élaboration des politiques législatives interdictives.Périodique
J. H. HALPERN | 2004ENGLISH : It is usually believed that drugs of abuse are smuggled into the United States or are clandestinely produced for illicit distribution. Less well known is that many hallucinogens and dissociative agents can be obtained from plants and[...]